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Acetyl-CoA:N-hydroxyarylamine O-acetyltransferase is an enzyme involved in the metabolic activation of N-hydroxyarylamines derived from muta-
genic and carcinogenic aromatic amines and nitroarenes. The O-acetyltransferase gene of Salmonella typhimurium has been cloned, and new Ames
tester substrains highly sensitive to mutagenic aromatic amines and nitroarenes have been established in our laboratory. The nucleotide sequence
of the O-acetyltransferase gene was determined. There was an open reading frame of 843 nucleotides coding for a protein with a calculated molecular
weight of 32,177, which was close to the molecular weight of the O-acetyltransferase protein determined by using the maxicell technique. Only the
residue of Cys69 in O-acetyltransferase of S. typhimurium and its corresponding residue (Cys68) in N-acetyltransferase of higher organisms were
69 conserved in all acetyltransferase enzymes sequenced so far. The amino acid sequence Arg-Gly-Gly-X-Cys, including the Cys , was highly con-
served. A mutant O-acetyltransferase of S. typhimurium, which contained Ala69 instead of Cys69, no longer showed the activities of 0- and N-
acetyltransferase. These results suggest that the Cys69 of S. typhimurium and the corresponding cysteine residues of the higher organisms are
essential for the enzyme activities as an acetyl-CoA binding site. We propose a new catalytic model of acetyltransferase for S. typhimurium and the
higher organisms. - Environ Health Perspect 102(Suppl 6):83-89 (1994)
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Introduction
Aromatic amines and nitroarenes, which
have been used in many fields and are
widely distributed in the environment, are
known as environmental hazardous com-
pounds because of their carcinogenicity
and mutagenicity (1-4). Neither aromatic
amines nor nitroarenes interact with DNA
per se, but they require metabolic conver-
sion for their mutagenesis (1-4). Several
activating enzymes, such as arylhydroxamic
acid N,0-acyltransferase (5), and sulfotrans-
ferase (6), have been identified as enzymes
This paper was presented at the Fifth International
Conference on Carcinogenic and Mutagenic
N-Substituted Aryl Compounds held 18-21 October
1992 in Wurzburg, Germany.
We are grateful to T. Watabe for helpful discus-
sion about the catalytic model. We wish to thank
P.D. Josephy for critically reading the manuscript.
This research was supported by a grant-in-aid from
the Japan Health Science Foundations. Masahiko
Watanabe was awarded a traveling grant from the
Ichiro Kanehara Foundation to attend the Fifth
International Conference on Carcinogenic and
Mutagenic N-Substituted Aryl Compounds.
Address correspondence to M. Watanabe, c/o H.
Mohrenweiser, Biomedical Sciences Division L-452,
Lawrence Livermore National Laboratory, PO Box
5507, Livermore, CA 94551. Telehpne (510) 423-
7545. Fax (510) 422-2282.
responsible for exerting the carcinogenicity
ofaromatic amines and nitroarenes. Acetyl-
CoA:N-hydroxyarylamine O-acetyltrans-
ferase (OAT) also plays an important role
in the metabolic activation of N-hydroxy-
arylamines that are formed by oxidation of
aromatic amines or by reduction of
nitroarenes (7-9). Acetyl-CoA:arylamine
N-acetyltransferases (E.C.2.3.1.5) (NAT)
of human (9), hamster (8,10,11), and
mouse (12) have OAT activity. Acetylator
genotypes of human (13,14), rabbit (15),
and hamster (13,16) strongly influence not
only NAT activity but also OAT activity.
It is suggested, therefore, that the mam-
malian OAT is probably the same enzyme
as NAT, which plays a major role in the
metabolism ofdrugs and endogenous sub-
stances that possess an amine or hydrazine
group (17,18). Both reactions ofN- and 0-
acetylation probably proceed through a
common intermediate (i.e., an acetyl-cys-
teinyl-enzyme) (12,19-21). cDNA and/or
genomic clones ofNATs have been isolated
from humans (22-27), rabbits (28-31),
hamsters (32), mice (33), and chickens
(34-36). Acetyltransferase activity is
demonstrated not only in the higher organ-
isms but also in bacteria (37). From
Salmonella typhimurium Ames tester strain
TA98, an acetyltransferase enzyme has
been partially purified and characterized as
OAT (38). The OAT is absent in strain
TA98/1,8-DNP6 (38) and plays a key role
in the mutagenicity ofaromatic amines and
nitroarenes (4,39,40).
In this article, we describe the cloning
ofthe S. typhimurium OAT gene (41). We
established new Ames tester substrains
highly sensitive to mutagenic aromatic
amines and nitroarenes using the doned gene
(42). Substrate specificity and inhibition
analysis suggested that the S. typhimurium
OAT is a counterpart of NAT of higher
organisms. Sequence similarity of both
enzymes at the amino acid level suggested
that the Cys69 ofthe S. typhimurium OAT
and the corresponding cysteine residues of
the NAT ofhigher organisms are essential
for the enzyme activities as an acetyl-CoA
binding site (43). We also proposed a com-
mon catalytic mechanism of acetyltrans-
ferase for S. typhimurium and higher
organisms.
Cloning ofthe S. typhimurium
OAT Gene
First, we constructed a gene library of S.
typhimurium TA1538 into vector plasmid
pBR322 and then selected rearranged plas-
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mids that confer resistance to the killing
effect of 2-nitrofluorene on the OAT defi-
cient strain TA1538/1,8-DNP. One of
these plasmids, pYG122 (Figure IA), had a
molecular size of 11.65 kb, composed of
the insert DNA (7.3 kb) and the vector
plasmid pBR322. The pYG122-trans-
formed strain YG1007 (=TA1538/1,8-
DNP(pYG122)) showed more than 10
times higher mutagenic sensitivity to 1,8-
dinitropyrene, 2-aminofluorene, and Glu-
P-1 than did the conventional strain
0 0.2 0.8
EH V V
11 /
TA1538 with vector plasmid pBR322.
YG1007 had about 50 times higher N-
hydroxy-Glu-P-1 OAT activity and isoni-
azid NAT activity than TA1538(pBR322).
Thus, we concluded that pYG122 had the
OAT gene.
In order to investigate the region neces-
sary for a functional OAT, we constructed
deletion derivatives ofpYG122 and found
that a 1.35-kb fragment spanning from the
EcoRV site (6.3 kb) to the BamHI site
(7.65 kb) is necessary for OAT activity.
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However, levels ofthe activity on the trans-
formants depended on organization of the
1.35-kb insert and vectors (Figure 1B). For
example, the strain having pYG219 showed
more than 10 times higher enzyme activity
than did the strain having pYG218. The
plasmids pYG218 and pYG219 have the
same 1.35-kb DNA fragment in opposite
directions. From this result, we suggested
that the direction of transcription and
translation of the OAT gene is from the
EcoRV site to the BamHI site and the pro-
moter for the OAT gene resides outside of
the 1.35-kb fragment.
I 7 EstablishmentofNewStrainsHighly
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Figure 1. (A) Restriction map of pYG122. The EcoRI restriction site derived from pBR322 was assigned the map
position of 0 kilobase (kb) in the plasmid. Numbers represent the distance (kb) from the EcoRI restriction site. An
open box represents the 7.3-kb DNA fragment of S. typhimurium TAl538, which was inserted into BamHl site of
pBR322. Arrows indicate the transcription direction of the genes. Abbreviations: Ap, ampicillin resistance gene; E,
EcoRI; H, Hindill; V, EcoRV; P, Pstl; B, BamHl; Pv, Pvull. (B) Involvement of promoters of vector sequence in the
activities of the S. typhimurium OAT produced from the 1.35-kb fragment. The plasmids were introduced into
S.typhimurium TA1538/1,8-DNP (pYG122, pYG213, pYG218, or pYG219) or E. coliXLI-Blue (pYG221) and N-
hydroxy-Glu-P-1 OAT activity of cytosol fraction of the transformants was measured. Numbers represent the activ-
ity of OAT(nmole/min/mg protein).
Table 1. Mutagenic sensitivity of YG1024 and YG1029 to typical N-hydroxyarylamines, aromatic amines, and
nitro-aromatic compounds.
Induced His+ revertants pernmolea
Chemical S9 mixb YG1020c YG1024d YG1025e YG1029f
N-Hydroxy-2-aminofluorene - 2,080 50,700 82 5,170
N-Hydroxy-Glu-P-1 - 7,800 69,400 84 3,000
2-Aminofluorene + 63 2410 20 551
Glu-P-1 + 8,090 144,000 430 5,970
2-Aminoanthracene + 351 6,060 292 7,450
2-Nitrofluorene - 47 1430 28 855
1-Nitropyrene - 373 3040 74 875
1,8-Dinitropyrene - 231,000 4,780,000 21,900 500,000
2-Nitronaphthalene - 2.9 12.9 11.2 36.5
4-Nitroquinoline N-oxide - 333 345 2470 2160
aSalmonella mutagenicity assays were carried out according to the method of Ames et al. combined with a prein-
cubation procedure for 20 min at37°C. The mutagenicity test was performed with four to eight doses. The number
of induced His+ revertants per nmole was calculated at every dose; the highest value for each chemical and strain
is indicated. b(+) indicates S9 mix was used for the metabolic activation. (-) indicates the test was performed in
the absence of S9 mix. cYG1020 is TA98 containing pBR322-ApS. dYG1024 is TA98 containing pYG219. "YG1025
is T100 containing pBR322-ApSfYG1029 is TA100 containing pYG219. The plasmid pBR322-ApS is the same as
pBR322 but its blagene is inactivated by deletion between the first Dralsite and the third Dralsite of pBR322.
A plasmid pYG219, the ampicillin resis-
tance gene ofwhich has been disrupted and
can be introduced into Ames tester strains
TA98 and TAl00, conferred high activity
ofOAT (Figure 1B) and high sensitivity to
2-nitrofluorene on the strain TA1538/1,8-
DNP. Thus we introduced pYG219 into
TA98 and TAl00, and resulting transfor-
mants YG1024 (=TA98(pYG219)) and
YG1029 (=TA100(pYG219)) were
checked for their mutagenic sensitivity to
typical N-hydroxyarylamines, aromatic
amines, and nitroarenes. YG1024 or
YG1029 showed 3 to 63 times higher sen-
sitivity to all N-hydroxyarylamines, aro-
matic amines and nitroarenes tested, except
for 4-nitroquinoline 1-oxide (Table 1),
than did the conventional strains YG1020
(=TA98(pBR322-Aps)) or YG1025
(= TA100(pBR322-Aps)), respectively.
This result indicates that the new strains
YG1024 and YG1029 permit the efficient
detection of the mutagenicity of environ-
mental aromatic amines and nitroarenes.
These strains have been widely used for the
efficient detection of mutagenic chemicals
(44-53) and complex mixtures (54-58).
Nucleotide Sequenceofthe
S.typhimuriumOAT Gene
We sequenced the cloned DNA from the
PstI site (5.55 kb) to the BamHI site (7.65
kb), the region that is suggested to carry
the OAT gene (Figure 1). The result is
shown in Figure 2. This sequence contains
an open reading frame of 843 bp from
nucleotides 853 to 1695 that potentially
encodes a protein of 281 amino acids with
a calculated molecular weight of 32,177. A
possible ribosome-binding site and a possi-
ble transcriptional terminator were found
upstream and at the end, respectively, of
the open reading frame. Possible -35 and
-10 sequences were found outside of the
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Figure 2. Nucleotide and deduced amino acid sequences of the S. typhimurium OAT gene. Possible -35 and -10
regions and Shine-Dalgarno (S.D.) sequence are underlined. Possible transcriptional terminator is indicated by
arrows and asterisks. The highly conserved amino acid sequence of R-G-G-X-C is marked with a double line. Cys69
is marked with a circle. The 1.35-kb DNA fragment that is boxed was subcloned into pBR322 for construction of
sensitive strains and pBluescript KS+ for DNA sequencing and for expression. The CCC sequence enclosed with a
small box indicates the site where a -1 frameshift mutation was found in 0-acetyltransferase deficient strain
TA1538/1,8-DNP.
Table 2. Properties of the S. typhimurium OAT and NATs of higher organisms.
Humana Hamsterb
S. typhimurium OAT M P M P
Molecular weightC 32,177 33,787 33,541 33,499
Cellular distribution C C C
O-Acetylation of
N-Hydroxy-Glu-P-1 + + + +
N-Hydroxy-2-aminofluorene + +
N-acetylation of
Isoniazid + - +
2-Aminofluorene + + + + +
p-Aminobenzoic acid +w + +w +
N,N-Acetyltransfer to
4-Aminoazobenzene - +
N,O-Acetyltransfer of
N-Hydroxy-2-acetylaminofluorene +w + +w
Inhibition by
N-Ethylmaleimide + + +
Paraoxon
Abbreviations: NAT, N-acetyltransferase; M, monomorphic NAT; P, polymorphic NAT; C, cytosol fraction.
"Data from Minchin et al. (9), Deguchi et al. (22), and Ohsaku and Deguchi (23). bData from Trinidad et al. (8),
Ozawa et al. (10), Abu-Zeid et al. (32), and Cheon and Hanna (63). CMolecular weight was calculated from
deduced amino acid sequences. Wweak. General characteristics of NAT(59): NAT is cytosolic and is widely distrib-
uted among tissues, with highest activities occurring in liver and intestinal tract. Most animal species have the
NAT. N-Ethylmaleimide is a potent inhibitor of the NAT. Paraoxon does not inhibit the NAT activity.
1.35-kb region. The rearranged plasmids,
which deleted DNA corresponding to
some C-terminal or N-terminal region of
the open reading frame, did not confer any
activity ofacetyltransferase. This result sug-
gests that the open reading frame is the
coding region of the OAT of S.
typhimurium. A protein with an approxi-
mate molecular mass of 33 kDa on SDS-
polyacrylamide gel electrophoresis was
identified in maxicells harboring pYG213
or pYG219, both of which have the
1.35-kb fragment. A frameshift mutation
was found in the open reading frame ofthe
OAT-deficient strain TAI538/1,8-DNP by
PCR and sequencing techniques. The
mutation is one G:C pair deletion from
three consecutive G:C pairs of nucleotides
1442 to 1444 in Figure 2 and creates a new
termination site at codon 204. From these
results, we concluded that the open reading
frame shown in Figure 2 is the coding
region ofthe OAT.
The S. taphimuriumOATis a
CounterpartofNATofHigher
Organisms
Because the OAT is present in cytosol, we
have prepared the cytosol fraction ofcrude
lysate of the cells harboring pYG221 and
subjected it to enzyme assays and inhibi-
tion experiments. Table 2 shows the proper-
ties of the OAT of S. typhimurium and
NATs ofhigher organisms for comparison.
Besides N-hydroxy-Glu-P-1 OAT activity,
the S. typhimurium OAT showed isoniazid
and 2-aminofluorene NAT activities. On
the other hand, many NATs of higher
organisms also show NAT and OAT activi-
ties. The molecular weight of the S.
typhimurium OAT was almost the same as
that ofthe NATs. The sulfhydryl-blocking
agents, which inhibit NAT of higher
organisms (59), strongly inhibited the iso-
niazid NAT activity ofthe S. typhimurium
OAT. Paraoxon, an inhibitor of N, O-
acetyltransferase and deacetylase (60), did
not inhibit the activity of the S.
typhimurium OAT. From these observa-
tions, we suggested that the S. typhimurium
OAT, the gene of which we cloned and
sequenced, is a counterpart of NAT of
higher organisms.
The S. tphimuriumOATand the
NATofHigher Organisms Share
Similarity attheAminoAcidLevel
Since the OAT of S. typhimurium is func-
tionally similar to NAT ofhigher organisms,
we compared the amino acid sequences.
The NATs of human, rabbit, hamster,
mouse, and chicken were at least 45%
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homologous at the amino acid level to each
other. The N-terminal region of the S.
typhimurium OAT, containing about 170
amino acids, showed 25 to 33% similarity
to those ofthe NATs ofhigher organisms at
the amino acid level (Figure 3). The remain-
ing C-terminal region ofthe OAT had few
similarities with the corresponding region
of the NATs, although some similarities
were observed at the nucleotide level.
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The Cys69 Residueofthe S.
tphimuniumOATandtheCys6
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EnzymeActivities
The S. typhimurium OAT is func
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both enzymes share similarity at th
acid level. These observations sugge
common catalytic mechanism miE
among them. Both enzymes need a
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Figure 3. Similarities in amino acid sequences between the S. typhimurium OAT and the NATs of human, rabbit,
hamster, mouse, and chicken. Abbreviations used and reference papers of the sequences are as follows: S.
typhimurium (S.T), this study (43); human liver monomorphic (Human-M),(23) human liver polymorphic (Human-P),
(23,26) rabbit monomorphic (Rabbit-M) (30) rabbit liver polymorphic (Rabbit-P) (28,29,31) hamster liver monomor-
phic (Hamster-M", (32) mouse monomorphic and polymorphic (Mouse-M and P) (33) chicken liver (Chicken-L) (34)
chicken pineal gland (Chicken-PG1 and PG2) (36). The deduced amino acid sequences of human liver monomorphic
and rabbit monomorphic NATs are also reported by Blum et al. (25) and Sasaki et al. (28), respectively, but their
sequences are different from those shown in this figure at three or one amino acids, respectively. It is reported
that slow acetylator-human also has human liver polymorphic gene but there are one or two amino acid differ-
ences from the gene in rapid acetylator (23,24,27). The amino acid residues that are conserved between the S.
typhimurium OAT and all the NATs of higher organisms are boxed. The cysteine residues of the S. typhimurium
OAT are indicated with asterisks, whereas those that are conserved among all the NATs of higher organisms are
indicated with #.
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NAT (19) and rabbit liver NAT (20) suggest
that a cysteine residue reacts with acetyl-
CoA and an activated acetyl-cysteinyl inter-
mediate is formed. Thus, we suggest that a
conserved cysteine residue among their
:tionally enzymes plays an important role in the cat-
sms and alytic mechanism as an acetyl-CoA-binding
.e amino site. The similarity at the amino acid level
.st that a between the S. typhimurium OAT and the
ght exist NATs of higher organisms was much less
cysteine than that of the NATs among the higher
tivities. organisms. Hence, it was easy to focus on
on liver the highly conserved regions. Among the
NATs ofhigher organisms, three cysteine
residues are conserved completely.
However, only one cysteine residue (Cys69 for the OAT, Cys6 for the NATs) was
conserved between the S. typhimurium
tGe i iYOAT and the NATs ofhigher organisms
(Figure 3). The amino acid sequence of
R-G-G-X-C including Cys69 of the OAT
or Cys of the NATs was highly con-
served. The results ofsite-directed mutage-
nesis experiments indicated that a mutant
2AEI PH OAT of S. typhimurium, which contained
IS Ala69 instead ofCys69, did not show any
[SG V1 NAT and OAT activities (data not shown).
:SGK QVP Thus, we suggest that the Cys residue of
rSG VP the OAT of S. typhimurium is essential for
rSGK1 2Ip the enzyme activities as an acetyl-CoA- [SGKt 2?P binding site. It was plausible that the Cys68
residue ofthe NATs ofhigher organisms is
also essential for the enzyme activities
;GKLTLTNFH because it was the only conserved residue
?SSVFITSKSF among all enzymes. Recently, Dupret and
?SSPFLKSI Grant (61) reported that among three cys-
?SSVPLDKSI teine residues that were highly conserved ?VSVFVNTSF 6 ?ASVFVSTSP among NATs of higher organisms, Cys68
?ASVFTSKSP
?DTILQKKSI was essential for the enzyme activities of ?DSLEvMCSI human liver polymorphic NAT. This
?DSLFTYSI observation supports our hypothesis that
there is a common catalytic mechanism
among acetyltransferase enzymes.
'TI
Proposed Mechanism of
Enzymatic Reactions of
Acetyltransferase Enzymes
Riddle and Jencks (62) showed that a gen-
eral base is involved in the catalysis of
pigeon liver NAT. Andres et al. (19) inves-
tigated the kinetics of NAT from pigeon
liver and proposed that a basic residue is
involved in a general base catalysis by
attracting the proton ofthe cysteine residue
of an acetyl-CoA-binding site. Recently,
Cheon and Hanna (63) reported that an
arginine residue is essential for the activity
of hamster liver monomorphic and poly-
morphic NATs. One arginine residue, Arg 5
in the S. typhimurium OAT and Arg in
the NATs ofhigher organisms, was highly
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Figure 4. (A) Proposed mechanism of the Salmonella typhimurium acetyl-CoA: N-hydroxyarylamine 0-acetyltrans-
ferase. (B) The conserved cysteine residues and their surrounding amino acid sequences of acetyltransferases of S.
typhimurium, humans, rabbits, hamsters, mice, and chickens. The abbreviations used are the same as those shown
in the legend of Figure 3. Basic amino acids are underlined. The highly conserved amino acids are boxed.
conserved. From our results and the results
ofothers, we postulate the reaction mecha-
nism of O-acetylation in the S.
typhimurium OAT as shown in Figure 4A.
The proton of cysteinyl group of Cys69
residue is attracted by Arg65 (or Arg )
residue, which is deprotonated even in
neutral pH conditions, because the two
adjacent guanidino groups ofArg64 and
Arg65 provide mutual electrostatic destabi-
lization (64). The activated Cys69 residue
accepts an acetyl group from acetyl-CoA,
resulting in an acetyl-cysteinyl-enzyme
intermediate. Finally, this acetyl moiety is
transferred to the oxygen atom of an N-
hydroxyarylamine. In the transfer reaction
of the acetyl group to the hydroxyamino
group, the deprotonated Arg (or Arg )
again serves as a general base. We propose
that the principle ofthis reaction mechanism
is applicable to any acyltransfer reactions in
both the S. typhimurium OAT and the
NATs of higher organisms. The S.
typhimurium OAT acts as an NAT when
the acetyl moiety of the acetyl-cysteinyl
intermediate is transferred to the nitrogen
atom of an aromatic amine instead ofthe
oxygen atom ofan N-hydroxyarylamine. It
is also proposed, with regard to mam-
malian NAT and OAT, that N- and 0-
acetyl transfer involves a common
acet%ylated enzyme intermediate (12,21).
Cys 8 residues ofthe NATs ofhuman, rab-
bit, hamster, mouse, and chicken could
bind with acetyl-CoA, as forCys69 ofthe S.
typhimurium OAT, whereas one of the
basic amino acids, (e.g., Arg64) may be an
activator (Figure 4B). The acetyl moiety of
the acetyl-Cys68 intermediate would be
transferred to the nitrogen atom (N-acety-
lation) or the oxygen atom (O-acetylation)
of an arylamine or N-hydroxyarylamine,
respectively. An arylhydroxamic acid also
may act as the acyl-donor instead ofacetyl-
CoA in the model, and the resulting acti-
vated acyl moiety would be transferred to
the nitrogen atom of an arylamine (N,N-
acyltransfer), or the oxygen atom ofan N-
hydroxyarylamine (inter and/or intra-
molecular N,O-acyltransfer). The S.
typhimurium OAT has low but measurable
N,0-acetyltransferase activity (Igarashi et al.,
unpublished result). One possible reason
why the S. typhimurium OAT has a low
N,O-acyltransferase activity is that an aryl-
hydroxamic acid could not easily fit in the
active site where the Cys69 probably
resides. However, we must point out that
certain N,O-acyltransferases have different
properties from the OAT and NAT: some of
the enzymes are located in microsomes and
are sensitive to paraoxon (60). The catalytic
mechanism of these enzymes is probably
different from that proposed in Figure 4A.
Future Perspective
We proposed a catalytic model for the S.
typhimurium OAT and suggested that this
model is applicable for NAT of higher
organisms. To examine this model, bio-
chemical and structural analyses of the
purified enzyme are important. Hence we
have been purifying the S. typhimurium
OAT from Escherichia coli cells harboring
plasmid pYG221, the cells which overpro-
duced the OAT (Figure 1B). Analyses of
enzymatic properties of the OAT, such as
demonstration ofthe acetyl-Cys69-enzyme
intermediate by using purified enzyme, are
currently being undertaken in our labora-
tory. For X-ray diffraction analysis, we are
trying to crystallize the purified OAT.
Knowledge about acetyltransferase at
the molecular level is rapidly growing. The
OAT and NAT are involved in the metab-
olism of drugs and toxic chemicals. We
hope that the new knowledge will also lead
to the design of new pharmaceuticals and
clinical kits, with possible human health
applications.
Conclusions
We have cloned the gene ofS. typhimurium
OAT and established new strains highly
sensitive to mutagenic aromatic amines and
nitroarenes. It is suggested that the Cys69
ofthe S. typhimurium OAT and the corre-
sponding cysteine residues of NAT of
higher organisms are essential for the
enzyme activities as an acetyl-CoA binding
site. We also propose a new catalytic mech-
anism of acetyltransferase for S.
typhimurium and higher organisms.
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